Trial Profile
Proof-of-concept endoscopic study of naproxen (OXP 005)
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2015
Price :
$35
*
At a glance
- Drugs Naproxen (Primary)
- Indications Musculoskeletal pain
- Focus Adverse reactions; Proof of concept
- Sponsors Oxford Pharmascience
- 10 Mar 2015 Title is not official; phase assumed; don't know if patients or volunteers.
- 10 Mar 2015 New trial record
- 05 Mar 2015 This study will be initiated after headline results have been reported from the phase I study (trial profile 700253545), according to an Oxford Pharmascience media release.